Tilray Brands Inc

General ticker "TLRY" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $1.1B

Tilray Brands Inc does not follow the US Stock Market performance with the rate: -27.2%.

Estimated limits based on current volatility of 5.2%: low 1.21$, high 1.34$

Factors to consider:

  • North America accounted for 51.8% of revenue in the fiscal year ended 2023-05-31
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-05-31 to 2026-05-31

  • 2024-05-31 to 2025-05-31 estimated range: [1.27$, 2.49$]
  • 2025-05-31 to 2026-05-31 estimated range: [1.43$, 2.72$]

Financial Metrics affecting the TLRY estimates:

  • Negative: Non-GAAP EPS, $ of -0.31 <= 0.10
  • Negative: Operating profit margin, % of -18.13 <= 1.03
  • Negative: Operating cash flow per share per price, % of -2.05 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0.07 <= 0.14

Similar symbols

Short-term TLRY quotes

Long-term TLRY plot with estimates

Financial data

YTD 2023-05-31 2024-05-31
Operating Revenue $627.12MM $788.94MM
Operating Expenses $1,996.81MM $963.69MM
Operating Income $-1,369.68MM $-174.75MM
Non-Operating Income $-80.50MM $-74.28MM
Interest Expense $13.59MM $49.26MM
R&D Expense $0.68MM $0.64MM
Income(Loss) $-1,450.18MM $-249.02MM
Taxes $-7.18MM $-26.62MM
Profit(Loss) $-1,443.00MM $-222.40MM
Stockholders Equity $3,315.69MM $3,442.91MM
Inventory $200.55MM $252.09MM
Assets $4,307.26MM $4,221.66MM
Operating Cash Flow $7.91MM $-30.91MM
Capital expenditure $20.80MM $29.25MM
Investing Cash Flow $-285.11MM $128.35MM
Financing Cash Flow $70.16MM $-75.19MM
Earnings Per Share* $-2.34 $-0.33

* EPS are Split Adjusted, recent splits may be reflected with a delay.